Type
1.
Parke-Davis. Promin and Promizole in tuberculosis and leprosy. Michigan: Parke, Davis & Company;.
Type
1.
Attewel. Book review: Aghor Medicine: Pollution, Death and Healing in Northern India by Ron Barrett. Social History of Medicine. 2008;(3):216.
Type
1.
Brand. The Care of the Eye. Treatment of HD. Carville: The Star; p. 15 p.
Type
1.
Parkash. Classification of leprosy into mutibacillary and paucibacillary groups: an analysis. Immunology & Medical Microbiology [Internet]. 2008;55(1):1-5. Available from: https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/femsim/55/1/10.1111/j.1574-695X.2008.00491.x/2/55-1-1.pdf?Expires=1500050041&Signature=G3dQLZgikyfG1D-piQoN-jX79qsX61Q2JYt8in0EnE1pM6xw8FzZB9c5BooHjRw~Uvga6G2svYIn0oTiAlG5Yednlza2U8SCXhbl
Type
1.
Walker, Kahawita. Post-kala-azar dermal leishmaniasis and borderline tuberculoid leprosy. British Journal of Dermatology. 2008;158(2):417.
Type
1.
White. Iatrogenic stigma in outpatient treatment for Hansen’s disease (leprosy) in Brazil. Health education research: theory and practice. 2008;23(1):25-39.
Type
1.
Kumar A, Girdhar A, Girdhar BK. Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study. BMJ Open [Internet]. 2012;2(4):e001403. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425897/pdf/bmjopen-2012-001403.pdf
Type
1.
Sopirala M, Wininger D, Ayers L. Acute Leprosy in Ohio during Treatment of HIV–AIDS. New England Journal of Medicine [Internet]. 2011;365:1549-51. Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMc1108255
Type
1.
Guo, Ao. Phage in the diagnosis and treatment of tuberculosis. Frontiers in Bioscience. 2012;17:2691-7.
Type
1.
International Federation of Anti-Leprosy Associations. ILEP Guía de Aprendizaje uno: Cómo diagnosticar y tratar la lepra. ILEP Guía de Aprendizaje. Londres: Federación Internacional de Asociaciones contra la Lepra (ILEP); 2002.